WASHINGTON, March 12 (Reuters) - Johnson & Johnson and the U.S. Food and Drug Administration warned of reported liver damage and death in patients taking the company’s HIV drug Prezista, according to a letter released on Wednesday.
WASHINGTON, March 12 (Reuters) - Johnson & Johnson and the U.S. Food and Drug Administration warned of reported liver damage and death in patients taking the company’s HIV drug Prezista, according to a letter released on Wednesday.
